The value of phase 4 clinical testing

被引：34

作者：

Vlahakes, GJ ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA 02115 USA

[2] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 04期

关键词：

D O I：

10.1056/NEJMe058272

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：413 / 415

页数：3

共 5 条

[1] APROTININ THERAPY FOR REOPERATIVE MYOCARDIAL REVASCULARIZATION - A PLACEBO-CONTROLLED STUDY [J].

COSGROVE, DM ;

HERIC, B ;

LYTLE, BW ;

TAYLOR, PC ;

NOVOA, R ;

GOLDING, LAR ;

STEWART, RW ;

MCCARTHY, PM ;

LOOP, FD .

ANNALS OF THORACIC SURGERY, 1992, 54 (06) :1031-1038

[2] The risk associated with aprotinin in cardiac surgery [J].

Mangano, DT ;

Tudor, IC ;

Dietzel, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) :353-365

[3] Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients? [J].

Schmartz, D ;

Tabardel, Y ;

Preiser, JC ;

Barvais, L ;

d'Hollander, A ;

Duchateau, J ;

Vincent, JL .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (01) :184-190

[4] Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children [J].

Seghaye, MC ;

Duchateau, J ;

Grabitz, RG ;

Jablonka, K ;

Wenzl, T ;

Marcus, C ;

Messmer, BJ ;

vonBernuth, G .

ANNALS OF THORACIC SURGERY, 1996, 61 (04) :1205-1211

[5]

WACHTFOGEL YT, 1993, J THORAC CARDIOV SUR, V106, P1

← 1 →